Caroline Solas
Inserm(FR)Aix-Marseille Université(FR)Hôpital de la Timone(FR)Institut de Recherche pour le Développement(FR)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Computational Drug Discovery Methods, HIV/AIDS drug development and treatment, Forensic Toxicology and Drug Analysis
Most-Cited Works
- → Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)(2022)67 cited
- → Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2(2020)46 cited
- → Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection(2020)46 cited
- → Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy(2012)12 cited
- → Validation of a non-targeted method devoted to identification and quantitation of toxicologically relevant compounds in plasma with HRMS(2023)10 cited
- → Seventy-two-hour stability of TaxolR in 5% dextrose or 0.9% sodium chloride in ViafloR, FreeflexR, EcoflacR and Macoflex NR non-PVC bags